James P Kesby (J P Kesby)

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Venues

Neuropsychiatric disease and treatment

Cognitive, affective & behavioral neuroscience

Schizophrenia (Heidelberg, Germany)

Addiction biology

UQ Queensland Brain Institute

University of Queensland (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UQ Queensland Brain Institute Mar 01 2019

Australia

UQ Amplify Fellow

UQ Queensland Brain Institute - Mar 01 2019

Australia

Advance Queensland Research Fellow

University of California San Diego

United States

Postdoctoral Research Fellow :: Department of Psychiatry

UQ Queensland Brain Institute

Australia

Postdoctoral Research Fellow

Education History

University of Queensland

Australia

PHD :: School of Biomedical Sciences

University of Queensland

Australia

BSC :: School of Biomedical Sciences

University of Queensland

Australia

BSC

Publications

Sunil Srivastav, Xiaoying Cui, Roger Bitencourt Varela, James P Kesby, Darryl Walter Eyles
Increasing dopamine synthesis in nigrostriatal circuits increases phasic dopamine release and alters dorsal striatal connectivity: implications for schizophrenia. Schizophrenia (Heidelberg, Germany) 9 (1) (2023)
Andrea Baker, Shuichi Suetani, Peter Cosgrove, Dan Siskind, Graham K Murray, James G Scott, James P Kesby
Reversal learning in those with early psychosis features contingency-dependent changes in loss response and learning. Cognitive neuropsychiatry (2023)
Urska Arnautovska, James P Kesby, Nicole Korman, Amanda L Rebar, Justin Chapman, Nicola Warren, Susan L Rossell, Frances L Dark, Dan Siskind
Biopsychology of Physical Activity in People with Schizophrenia: An Integrative Perspective on Barriers and Intervention Strategies. Neuropsychiatric disease and treatment 18 (2022)
Urska Arnautovska, James P Kesby, Nicole Korman, Amanda L Rebar, Justin Chapman, Nicola Warren, Susan L Rossell, Frances L Dark, Dan Siskind
Biopsychology of Physical Activity in People with Schizophrenia: An Integrative Perspective on Barriers and Intervention Strategies. Neuropsychiatric disease and treatment 18 (2022)
Shuichi Suetani, Andrea Baker, Kelly Garner, Peter Cosgrove, Matilda Mackay-Sim, Dan Siskind, Graham K Murray, James G Scott, James P Kesby
Impairments in goal-directed action and reversal learning in a proportion of individuals with psychosis. Cognitive, affective & behavioral neuroscience 22 (6) (2022)
Jonathan Flintoff, James P Kesby, Dan J Siskind, Thomas H J Burne
Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential. Expert opinion on investigational drugs 30 (8) (2021)
Xiaoying Cui, Renata Ap Nedel Pertile, Zilong Du, Wei Wei, Zichun Sun, Darryl W Eyles, James P Kesby
Developmental Inhibition of Long Intergenic Non-Coding RNA, HOTAIRM1, Impairs Dopamine Neuron Differentiation and Maturation. International journal of molecular sciences 22 (14) (2021)
James P Kesby, D W Eyles, John G McGrath, J G Scott
Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience. Translational psychiatry 8 (1) (2018)
James P Kesby, Ariel Chang, Athina Markou, Svetlana Semenova
Modeling human methamphetamine use patterns in mice: chronic and binge methamphetamine exposure, reward function and neurochemistry. Addiction biology 23 (1) (2017)

James P Kesby.css-eqlu8i{font-size:small;padding-left:4px;} (J P Kesby)

Publication Activity (10 Years)

Top Topics

Top Venues

James P Kesby (J P Kesby)